Why Terveystalo stock moves
Terveystalo rose clearly, without company news explaining it.
Written after the close on ·
Why today
16,307 news analyzed todayTerveystalo rose clearly, without company news explaining it.
It moved against OMX Helsinki 25, which fell slightly over the same day.
Over the last five trading days it rose clearly, well ahead of the slight rise in the market.
The move was big for Terveystalo, about twice a normal five-day stretch, and such moves happened about ten times in the past year.
Today's move of +0.81% was 1.0 times a normal day's 0.8%. OMX Helsinki 25 moved −0.52% on the same day.
Terveystalo +0.81%OMX Helsinki 25 −0.52%Against the market
What analysts expect, and how often they have been right
Analysts’ estimates for Terveystalo.
Terveystalo earned more than expected in 2 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 5 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 6.23 EUR
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedEUR
Next reported quarter: expected earnings per share of 0.20 EUR (February 12). For the current fiscal year, expected earnings per share changed from 0.65 EUR three months ago to 0.57 EUR now. 2026 estimate: 0.57 EUR. 2027 estimate: 0.59 EUR.
Has the share price followed the business?
Price and earnings moved in the same direction: 1 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed −7% and earnings per share +28%.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn EUR
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn EUR
Price and earnings moved in the same direction: 1 out of 3 years.Market cap (Now): 790 m EURRevenue 2025: 1.3 bn EUR
What the key figures say about Terveystalo
The figures connect what Terveystalo earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -0.33 EUR–0.73 EUR. Peers: COMPASS Pathways -$2.34, Humana 3.69 SEK, Pihlajalinna 0.79 EUR. 2026 estimate: 0.57 EUR (0.53 EUR–0.60 EUR). 2027 estimate: 0.59 EUR (0.57 EUR–0.64 EUR).
What the company sold during the year.
2022–2025: 1.3 bn EUR–1.3 bn EUR. Peers: Humana 10.1 bn SEK, Pihlajalinna 542 m EUR. 2026 estimate: 1.2 bn EUR (1.2 bn EUR–1.2 bn EUR). 2027 estimate: 1.4 bn EUR (1.2 bn EUR–1.5 bn EUR).
The percentage of revenue left after the costs of running the business.
2022–2025: 5.2%–11.0%. Peers: Humana 4.3%, Pihlajalinna 6.1%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −8.2%–15.9%. Peers: COMPASS Pathways −296.5%, Humana 5.4%, Pihlajalinna 10.8%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 13.4–32.9. Peers: Humana 19.2, Pihlajalinna 10.6. 2026 estimate: 11.0. 2027 estimate: 10.5.
What investors pay for each unit the company sells.
2022–2025: 0.63–0.99. Peers: Humana 0.33, Pihlajalinna 0.35. 2026 estimate: 0.66. 2027 estimate: 0.55.
Money paid to shareholders per share, summed by calendar year.
2018–2025: 0.06 EUR–0.48 EUR.
The ordinary yearly dividend as a percentage of the share price. Across Nordic companies, a yield of this size was followed by a lower dividend the next year in about 55% of cases, against about 17% below 5%.
2022–2025: 2.9%–4.9%. Peers: COMPASS Pathways 0.0%, Humana 0.0%, Pihlajalinna 6.3%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 2.17–6.59. Peers: Humana 7.64, Pihlajalinna 6.77.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 1.34–2.43. Peers: COMPASS Pathways 8.58, Humana 1.03, Pihlajalinna 1.10.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 12.8–33.4.
Cash left after investments, divided by the number of shares.
2022–2025: 0.65 EUR–1.45 EUR. Peers: COMPASS Pathways -$1.25, Humana 16.56 SEK, Pihlajalinna 1.87 EUR.
The percentage of assets financed by shareholders’ equity.
2022–2025: 36.3%–40.5%.
The dividend explained
A dividend is money paid to shareholders. Terveystalo paid 0.64 EUR per share in the twelve months through November 6, 2026.
On the ex-dividend day, October 7, 2026, Terveystalo traded without the right to the 0.32 EUR dividend. The price went from 7.48 EUR to 7.05 EUR; including the dividend, the day's change was −1.5%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.
2018: 0.06 EUR2019: 0.20 EUR2020: 0.13 EUR2021: 0.26 EUR2022: 0.28 EUR2023: 0.28 EUR2024: 0.30 EUR2025: 0.48 EUR2026 so far: 0.64 EUR
What to watch next, and why
The earnings report shows how Terveystalo's revenue and profit have changed.
- Earnings report
The earnings report shows how Terveystalo's revenue and profit have changed.
Add to calendar
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Terveystalo usually moved about 2.8%. On a normal day it moves 0.8%.
+0.31% +0.00% −6.37% −1.12%
10,000 EUR in Terveystalo bought on October 11, 2017 is worth 8,370 EUR today, with dividends reinvested.
The same amount in OMX Helsinki with dividends would have become 19,700 EUR.
What would 10,000 EUR in Terveystalo be worth today? →
What would 10,000 EUR in Terveystalo be worth today?
8,370 EUR
with dividends reinvested, bought on October 11, 2017. The same amount in OMX Helsinki with dividends would have become 19,700 EUR.
At worst it was worth 6,660 EUR (December 19, 2022).
The five biggest days of the journey
· −14.7% · the whole market rose 1.5% the same day
· −9.5% · the whole market rose 0.1% the same day · report day
· +9.2% · the whole market rose 0.5% the same day
· −9.1% · the whole market rose 3.5% the same day · report day
· −9.0% · the whole market rose 1.2% the same day · report day
Earlier days
−1.12% market −0.56% Terveystalo fell clearly without a company-news explanation. Read →
Terveystalo fell clearly without a company-news explanation.
Over the same day the OMX Helsinki 25 fell slightly, so Terveystalo moved more than the market.
Over the last five trading days the stock rose clearly while the market was roughly flat.
The move is big for Terveystalo, about twice a normal five-day stretch, and such moves happened about 12 times in the past year.
The latest close sits well below the highest close of the past year, reached in early February.
+2.80% market +1.42% Terveystalo rose very sharply without a company-news explanation. Read →
Terveystalo rose very sharply without a company-news explanation.
The market, OMX Helsinki 25, also rose sharply, so Terveystalo moved more than the market.
The move was very big for Terveystalo, about four times a normal day, on well below usual trading volume.
No company news explains it, so it likely reflects broader buying interest in the shares.
Over the last five trading days Terveystalo rose sharply while the market was roughly flat.
+0.17% market +0.36% Terveystalo barely moved, less than the market. Read →
Terveystalo barely moved, less than the market.
This did not move the shares much.
Over the last five trading days the stock fell clearly, about twice a normal five-day move, while OMX Helsinki 25 fell slightly.
Likely drivers include weak third-quarter results and margin pressure reported in late October.
+0.50% market −1.25% Terveystalo rose slightly without company news. Read →
Terveystalo rose slightly without company news.
Terveystalo rose slightly while OMX Helsinki 25 fell clearly, so it moved against the market.
The move was an ordinary-sized one for Terveystalo, within its usual daily range.
Over the last five trading days, Terveystalo rose slightly while the market was roughly flat.
The stock sits well below its past-year high and near its low, after a profit warning and weak third-quarter results.
+1.34% market +0.22% Terveystalo rose slightly over the week while the Helsinki market was roughly flat. Read →
Terveystalo rose slightly over the week while the Helsinki market was roughly flat.
Its moves were ordinary for the stock, with no major company news inside the week itself.
Most of the week's news dates to before the period: the 20 October profit warning and the 21 October weak third-quarter results.
Next, the company reports full-year results on 12 February 2027.
−0.66% market −0.58% Terveystalo fell slightly, in line with the market. Read →
Terveystalo fell slightly, in line with the market.
Over the last five trading days, Terveystalo fell very sharply, much more than the broader Helsinki market, which fell slightly.
The drop followed weak third-quarter results, lower revenue and a guidance cut, which analysts and investors reacted to.
Analysts including Nordea and Inderes cut their price targets, the fair share price they see, after the report.
−3.36% market −0.14% Terveystalo fell, moving against a flat market. Read →
Terveystalo fell, moving against a flat market.
Over the same day, OMX Helsinki 25 was roughly unchanged, so the drop was specific to Terveystalo.
Over the last five trading days, Terveystalo fell sharply, a very big move for this stock.
The share has been under pressure since last week's weak third-quarter results and guidance cut, which lowered profit expectations.
+4.87% market +1.83% Terveystalo rose sharply without a company-news explanation. Read →
Terveystalo rose sharply without a company-news explanation.
Over the same day, OMX Helsinki 25 also rose sharply, so Terveystalo moved in line with the market rather than apart from it.
The move came after a weak third quarter and a profit warning last week, which likely left the shares heavily sold and open to a rebound.
Over the last five trading days, Terveystalo fell very sharply while the market was roughly flat, after the profit warning cut its 2026 operating profit guidance to EUR 110–120 million.
The next earnings report is Friday 12 February 2027.
−4.94% market −0.38% Terveystalo fell very sharply, with no new company news explaining the move. Read →
Terveystalo fell very sharply, with no new company news explaining the move.
The shares moved far more than OMX Helsinki 25, which fell only slightly.
The move was very big for Terveystalo, rare in the past year.
Trading was heavier than usual, about twice a normal session.
Over the last five trading days the stock fell very sharply, and the market fell clearly too.
−15.94% market −3.27% Terveystalo fell very sharply over the last five trading days, far more than the broader Helsinki market. Read →
Terveystalo fell very sharply over the last five trading days, far more than the broader Helsinki market.
The main driver was a profit warning issued on Tuesday, when the company cut its full-year 2026 profit guidance, citing weaker demand in July to September and weaker occupational healthcare volumes.
The third-quarter report, published earlier in the week, confirmed the weak demand and lower adjusted operating profit (EBIT, earnings before interest and tax).
Analysts then lowered their price targets, the share prices they see as fair value, with Nordea and Inderes both cutting theirs on Thursday.
−1.88% market −1.41% Terveystalo fell sharply, following a profit warning issued on Tuesday. Read →
Terveystalo fell sharply, following a profit warning issued on Tuesday.
The fall was very big for Terveystalo, rarer than any move of that size in the past year.
Over the last five trading days it fell very sharply, while OMX Helsinki 25 fell only slightly.
The most likely reason is the profit warning: the company cut its 2026 profit outlook after weak demand in occupational healthcare.
Analysts also cut their fair value estimates, and the next earnings report comes on 12 February 2027.
Learn more · Why do stocks go up and down?